39611159|t|Heme catabolism and heme oxygenase-1-expressing myeloid cells in pathophysiology.
39611159|a|Although the pathological significance of myeloid cell heterogeneity is still poorly understood, new evidence indicates that distinct macrophage subsets are characterized by specific metabolic programs that influence disease onset and progression. Within this scenario, distinct subsets of macrophages, endowed with high rates of heme catabolism by the stress-responsive enzyme heme oxygenase-1 (HO-1), play critical roles in physiologic and pathological conditions. Of relevance, the substrates of HO-1 activity are the heme groups that derive from cellular catabolism and are converted into carbon monoxide (CO), biliverdin and Fe2+, which together elicit anti-apoptotic, anti-inflammatory activities and control oxidative damage. While high levels of expression of HO-1 enzyme by specialized macrophage populations (erythrophagocytes) guarantee the physiological disposal of senescent red blood cells (i.e. erythrocateresis), the action of HO-1 takes on pathological significance in various diseases, and abnormal CO metabolism has been observed in cancer, hematological diseases, hypertension, heart failure, inflammation, sepsis, neurodegeneration. Modulation of heme catabolism and CO production is therefore a feasible therapeutic opportunity in various diseases. In this review we discuss the role of HO-1 in different pathological contexts (i.e. cancer, infections, cardiovascular, immune-mediated and neurodegenerative diseases) and highlight new therapeutic perspectives on the modulation of the enzymatic activity of HO-1.
39611159	0	4	Heme	Chemical	MESH:D006418
39611159	20	36	heme oxygenase-1	Gene	3162
39611159	412	416	heme	Chemical	MESH:D006418
39611159	460	476	heme oxygenase-1	Gene	3162
39611159	478	482	HO-1	Gene	3162
39611159	581	585	HO-1	Gene	3162
39611159	603	607	heme	Chemical	MESH:D006418
39611159	675	690	carbon monoxide	Chemical	MESH:D002248
39611159	692	694	CO	Chemical	MESH:D002248
39611159	697	707	biliverdin	Chemical	MESH:D001664
39611159	712	716	Fe2+	Chemical	-
39611159	761	773	inflammatory	Disease	MESH:D007249
39611159	850	854	HO-1	Gene	3162
39611159	1025	1029	HO-1	Gene	3162
39611159	1099	1101	CO	Chemical	MESH:D002248
39611159	1134	1140	cancer	Disease	MESH:D009369
39611159	1142	1164	hematological diseases	Disease	MESH:D006402
39611159	1166	1178	hypertension	Disease	MESH:D006973
39611159	1180	1193	heart failure	Disease	MESH:D006333
39611159	1195	1207	inflammation	Disease	MESH:D007249
39611159	1209	1215	sepsis	Disease	MESH:D018805
39611159	1217	1234	neurodegeneration	Disease	MESH:D019636
39611159	1250	1254	heme	Chemical	MESH:D006418
39611159	1270	1272	CO	Chemical	MESH:D002248
39611159	1391	1395	HO-1	Gene	3162
39611159	1437	1443	cancer	Disease	MESH:D009369
39611159	1445	1455	infections	Disease	MESH:D007239
39611159	1457	1471	cardiovascular	Disease	MESH:D002318
39611159	1473	1488	immune-mediated	Disease	MESH:C567355
39611159	1493	1519	neurodegenerative diseases	Disease	MESH:D019636
39611159	1611	1615	HO-1	Gene	3162
39611159	Association	MESH:D007239	3162
39611159	Association	MESH:D001664	3162
39611159	Association	MESH:D002248	MESH:D007249
39611159	Association	MESH:D002248	3162
39611159	Association	MESH:D002248	MESH:D006402
39611159	Association	MESH:C567355	3162
39611159	Association	MESH:D019636	3162
39611159	Association	MESH:D002248	MESH:D006973
39611159	Association	MESH:D001664	MESH:D006418
39611159	Association	MESH:D002248	MESH:D009369
39611159	Association	MESH:D002248	MESH:D006333
39611159	Association	MESH:D006973	3162
39611159	Negative_Correlation	MESH:D001664	MESH:D007249
39611159	Association	MESH:D009369	3162
39611159	Association	MESH:D018805	3162
39611159	Association	MESH:D006402	3162
39611159	Association	MESH:D002248	MESH:D019636
39611159	Association	MESH:D002248	MESH:D006418
39611159	Association	MESH:D006333	3162
39611159	Association	MESH:D002248	MESH:D018805
39611159	Association	MESH:D002318	3162
39611159	Association	MESH:D006418	3162

